ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FAB Fusion Antibodies Plc

3.45
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.45 3.30 3.60 3.45 3.45 3.45 25,672 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0272 -1.27 3.29M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.45p. Over the last year, Fusion Antibodies shares have traded in a share price range of 3.10p to 9.875p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £3.29 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -1.27.

Fusion Antibodies Share Discussion Threads

Showing 4001 to 4024 of 4100 messages
Chat Pages: 164  163  162  161  160  159  158  157  156  155  154  153  Older
DateSubjectAuthorDiscuss
03/3/2024
21:16
Some decent news after placing and 7 should not be an issue
bigjock36
01/3/2024
11:19
Nice to see a bit of action back, another assault on 7s please, GLA
lawson27
01/3/2024
11:02
I have, but have been several of the larger buys since last Thursday last week, so been happy with the way the price action has gone...
troutisout
01/3/2024
09:14
Anyone else noticed a regular pattern with this. An immediate sell of a few thousand at the start of the day to weaken the price, and then multiple larger buys throughout the day
ksddw2
27/2/2024
12:33
Agree soultrading-cash roughly 60% of market cap and little snippets, like this am's deal, small as it is, all help and happy to see them them getting a few more over the next year so they can gain traction within the field. What is important here is not the amount but the fact a tiny Belfast company's antibody library is even sufficiently worthwhile that a global diagnostics company, and the US NCI would even be aware of it.
The science must be OK-all it takes is one tiny break....but they will be snapped up soon imo.

cumnor
27/2/2024
11:23
Probably the best time to buy for a while. Funded with anticipated news flow makes the current cap look like an opportunity.Once the placees get their shares we can expect a real ramp. As shard did the book build we can add 6% on to 4p just for their break even price and I bet they want a lot more, as I am aware a chunk are sticky.Director options are 4.25 which implies that they believe the price will be way north of that.Those new or reinvesting have an opportunity to get in at a decent level and with funding sorted it eliminates some risk.
soultrading
27/2/2024
10:31
"Fusion Antibodies (FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announced it has received a first purchase order under the master services agreement (MSA) with a leading diagnostics company details of which were announced on 14 February 2024. FAB said reaching this agreement with a world class diagnostics provider positively reinforces the value to the wider commercial world of Fusion Antibodies’ technologies and capabilities. In this case it is the generation of antibodies in diagnostics products.

Comment: It could be argued that fundamentally FAB is now on track as a recovery situation, with the purchase order and recent funding. Only a rise in the share price is missing."

troutisout
15/2/2024
14:27
behave abbeygale ! prior to the placing their was less shares in issue &

Granted with volume the Sp marched North, so now the prospects of more shares

in issue weakens the "Eps ! giving a lower share value & a realistic value

Due South....The Law of Gravity ?...Every day is a School Day !

dreamtwister
15/2/2024
14:01
I have not fallen for the selling this time round. As I know how quickly it goes back up.
luckyabbeygale
15/2/2024
10:06
Latest broker note

hxxps://wp-allenby-2020.s3.eu-west-2.amazonaws.com/media/2024/02/20240215-Fusion-Antibodies-plc-FAB.L-Allenby-Capital-Update.pdf?c4036=on

gtc1508
14/2/2024
13:13
i notice abbey has got her grannie Knickers on ....lol...(y)
dreamtwister
14/2/2024
13:07
careful jock the share price will dip below the price of the placings.
dreamtwister
14/2/2024
12:59
With the 200K sale at 4p and overhang to clear made me think this is dead.
I had to buy back the half I sold for 0.2p more. The MM has to get so many sells in order for the huge rise to begin. Therefore I may of helped make these better.

luckyabbeygale
14/2/2024
12:44
Good churn the holders will do well
bigjock36
14/2/2024
12:15
I currently have an avg of 4.7 and will be buying around these levels to further bring my avg downThey are fully funded raising at 4pThis will do well fromHere
bigjock36
14/2/2024
11:36
Unfortunately it is very predictable and more than likely right what they say. Not much to get excited about here at all
bones698
14/2/2024
11:08
Always the same JakNife and clock tower working in tandem
bigjock36
14/2/2024
10:14
^^ what clocktower said

I really don't understand why the longs couldn't see this coming. Anyone should be able to do the really basic maths to see that FAB is a sub-scale business that needs a dramatic transformation before it will become profitable. The consequence of it NOT being profitable is that it's loss-making and hence cash-burning and dependent on regular fund raises.

They raised £1.56m at 5p in May last year and now have raised £1.38m at 4p. Who will be surprised if they raise another £1.4m a year from now at 3p? You shouldn't be!

JakNife

jaknife
14/2/2024
09:14
Like many others it's just tunneling value from shareholders and AIM is the worst for doing so, from a PI's point of view but warnings were given repeatedly before the first placing, at a huge discount when WTP was ramping it, as he had loaded himself with the directors guff and sunk a huge amount of funds into the deep mine of dreams.
clocktower
14/2/2024
08:07
It will but the market isn't putting much chance of success on it performing. Down again to the placing price shows this.

Needs some major contracts wins and to turn a profit which are some way off yet

bones698
14/2/2024
07:50
The business will now survive until at least 2025 H2Plenty of time to get contracts in and progress the business
bigjock36
14/2/2024
07:43
After getting fleeced in the last placing at a 84% discount at least this one is not as bad but it shows more cash keeps being needed. No clarity on breakeven yet and needs more contracts still before it reaches that point.
Gives them another 12 months to get sorted and win more contracts at least

bones698
14/2/2024
07:40
Good news.
cumnor
14/2/2024
07:39
I see they are even trying to get me to sell my Redrock that could be about to have a 8m court win this week.
luckyabbeygale
Chat Pages: 164  163  162  161  160  159  158  157  156  155  154  153  Older

Your Recent History

Delayed Upgrade Clock